Botulinum toxin treatment in gastrointestinal disorders

Ammar Nassri, Kaveh Sharzehi, Ron Schey

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Botulinum toxin is used extensively for the management of gastrointestinal smooth muscle disorders. This chapter is a summary of the current status of this therapy. Botulinum toxin appears to be beneficial for achalasia, hypertensive esophageal disorders, and anal fissure and unclear utility in gastroparesis, upper esophageal sphincter dysfunction, and sphincter of Oddi dysfunction. Very few placebo-controlled trials have been performed despite widespread use of toxin for the past 25 years. Botulinum toxin appears to be safe and side effects are uncommon. Despite uncontrolled data, botulinum toxin is now used for a variety of spastic disorders of GI smooth muscle. In some instances, this therapy may preclude the need for more invasive treatments. Controlled trials are needed.

Original languageEnglish (US)
Title of host publicationBotulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine
PublisherSpringer
Pages283-295
Number of pages13
ISBN (Electronic)9783030506919
ISBN (Print)9783030506902
DOIs
StatePublished - Oct 6 2020

Keywords

  • Achalasia
  • Anal fissure
  • Botulinum toxin
  • Gastroparesis
  • Hypertensive esophageal disorders
  • Sphincter of Oddi dysfunction

ASJC Scopus subject areas

  • General Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • General Dentistry
  • General Veterinary

Fingerprint

Dive into the research topics of 'Botulinum toxin treatment in gastrointestinal disorders'. Together they form a unique fingerprint.

Cite this